COMMUNIQUÉS West-GlobeNewswire

Tyme Technologies Announces Pricing of its $12 Million Registered Offering
29/03/2019
NEW YORK, March 29, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) announced today that it has priced a registered offering of 8 million shares of its common stock, par value $0.0001 per share, and [...]
Cytori to Webcast Fourth Quarter and 2018 Financial Results on April 1
29/03/2019
SAN DIEGO, March 29, 2019 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will provide a live webcast of its fourth quarter and year-end financial results and business update on Monday, April 1, 2019 at 8: [...]
Spero Therapeutics Receives FDA Fast Track Designation for SPR994 for the treatment of Complicated Urinary Tract infections and Acute Pyelonephritis
29/03/2019
CAMBRIDGE, Mass., March 29, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
eFFECTOR Presents Data on its Selective Translation Regulators at AACR 2019 Annual Meeting
29/03/2019
SAN DIEGO, March 29, 2019 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced that data from all three of [...]
Nephros to Present at the Spring Investor Summit on April 1st in New York City
29/03/2019
SOUTH ORANGE, NJ, March 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB:NEPH), a commercial stage company that develops and sells high performance liquid purification filters for both medical [...]
Entasis Therapeutics Reports Full Year 2018 Financial Results and Provides Business Update
29/03/2019
On track to commence two Phase 3 clinical trials in 2019 WALTHAM, Mass., March 29, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the [...]
Filing of Annual Report on Form 20-F
29/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Files US Annual Report on Form 20-F Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader [...]
Auxly Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Outlook for 2019
29/03/2019
VANCOUVER, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") today released its fourth quarter and full year 2018 financial results [...]
Axovant Announces Clinical Updates from AXO-AAV-GM2 and AXO-Lenti-PD Studies
29/03/2019
-R&D Day featuring leading physicians and scientists in Parkinson’s disease, GM1 gangliosidosis and GM2 gangliosidosis (Tay-Sachs disease) will be webcast today at 8:30a.m. ET from New York- -Approximately 25% [...]
Emerald Health Therapeutics Delivers to Yukon and Adds Supply Agreements with Alberta and Saskatchewan
29/03/2019
VANCOUVER, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has fulfilled its first purchase order of cannabis from Yukon Liquor Corporation, [...]
ASLAN Pharmaceuticals Completes First Part of Single Ascending Dose Study for ASLAN004 Targeting Atopic Dermatitis
29/03/2019
Interim results support competitive efficacy, potential for monthly dosing and favourable safety profile SINGAPORE, March 29, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage [...]
Change in number of shares and votes in Saniona AB (publ)
29/03/2019
PRESS RELEASE March 29, 2019 During March, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]
Health Canada grants Nexstim NBS system and NexSpeech® medical device license for Canada
29/03/2019
Company announcement, Helsinki, 29 March 2019 at 9.30 am (EET) Health Canada grants Nexstim NBS system and NexSpeech® medical device license for Canada Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), [...]
Publication of Biohit Oyj Annual Report 2018
29/03/2019
Biohit Oyj Annual Financial Report March 29, 2018 at 9:30 am local time (EET) Biohit Oyj’s Annual Report 2018 is published today in PDF format. The annual report contains financial statements for 2018, the Report of the [...]
Notice of Biohit Oyj’s Annual General Meeting
29/03/2019
Notice of Biohit Oyj’s Annual General Meeting Biohit Oyj Stock Exchange Release March 29, 2019 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held [...]
Laboratory set up in Berlin and strategic collaboration with leading German and Danish cancer coorporative groups entered to develop precision medicine for women’s cancers
29/03/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, March 29, 2019 – Oncology Venture A/S (“OV” or “the Company”) , today announces a new important strategic collaboration to develop precision medicine for women’s [...]
Share capital and voting rights in Orphazyme A/S
29/03/2019
Orphazyme A/S Company announcement No. 11/2019 Company Registration No. 32266355 Copenhagen, March 29, 2019 – Following a share capital increase in Orphazyme A/S (ticker: ORPHA.CO), CVR no. 32266355 (“Orphazyme”) in [...]
Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in China
29/03/2019
LONDON, March 29, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a registration-enabling Phase IIb/III study comparing surufatinib (HMPL-012 or sulfatinib) with [...]
IBA sélectionnée pour l’installation d’un centre de protonthérapie à cinq salles à Shenzhen, en Chine
29/03/2019
IBA sélectionnée pour l’installation d’un centre de protonthérapie à cinq salles à Shenzhen, en Chine Les négociations du contrat final débuteront dans les prochaines semaines Louvain-la-Neuve, Belgique, le 29 mars 2019 [...]

Pages